loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 210920 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Bionpharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DEFERASIROX (3)

    filter

    01 BIONPHARMA (3)

    filter

    01 TABLET, FOR SUSPENSION;ORAL (3)

    filter

    01 125MG (1)

    02 250MG (1)

    03 500MG (1)

    filter

    01 USA (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Deferasirox

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET, FOR SUSPENSION...
      500MG
      DEFERASIROX
      USA
      210920
      2019-11-20
      RX
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Deferasirox

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET, FOR SUSPENSION...
        125MG
        DEFERASIROX
        USA
        210920
        2019-11-20
        RX
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Deferasirox

          PDF Supplier PDF
          URL Supplier Web Content
          TABLET, FOR SUSPENSION...
          250MG
          DEFERASIROX
          USA
          210920
          2019-11-20
          RX
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for CTD TGA MCC DOSSIER APPLICATION 210920

          Looking for CTD TGA MCC DOSSIER APPLICATION 210920 3

          19

          Bionpharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is DEFERASIROX, with a corresponding application number 210920 and regulatory information .

          proudly manufactured in the

          approval since 2019-11-20

          Bionpharma's DEFERASIROX TABLET, FOR SUSPENSION;ORAL, medication with 500MG of DEFERASIROX.

          18

          Bionpharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is DEFERASIROX, with a corresponding application number 210920 and regulatory information .

          proudly manufactured in the

          approval since 2019-11-20

          Bionpharma's DEFERASIROX TABLET, FOR SUSPENSION;ORAL, medication with 125MG of DEFERASIROX.

          17

          Bionpharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is DEFERASIROX, with a corresponding application number 210920 and regulatory information .

          proudly manufactured in the

          approval since 2019-11-20

          Bionpharma's DEFERASIROX TABLET, FOR SUSPENSION;ORAL, medication with 250MG of DEFERASIROX.

          Post Enquiry
          POST ENQUIRY